Delcath Systems rises as co expects wider-than-estimated Q3 revenue

Delcath Systems

17/10/2024 17:50

Oct 17 (Reuters) -    ** Shares of medical device maker
Delcath Systems Inc  DCTH.O  up 5.8% at $10.06
    ** Co expects Q3 revenue of $11.2 mln, above analysts'
average estimate of $9.45 mln, according to data compiled by
LSEG 
    ** Co says it recorded $10 mln in U.S. revenue in Q3 from
commercialization of Hepzato Kit, a drug-device combination
product for cancer treatment
    ** DCTH says $10 mln quarterly U.S. revenue milestone
triggers $25 mln financing tranche, which it will utilize to
support ongoing commercial launch and invest in new trials to
expand indications it plans to initiate in 2025
    ** Co to announce quarterly financial results on Nov. 8
    ** Up to last close, stock up ~140.98% YTD

 (Reporting by Rishab Shaju in Bengaluru)
 ((Rishab.Shaju@thomsonreuters.com;))